Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report)'s stock price was down 1.1% during trading on Monday . The stock traded as low as €27.64 ($32.52) and last traded at €27.67 ($32.55). Approximately 3,613,197 shares changed hands during mid-day trading, The stock had previously closed at €27.97 ($32.91).
Bayer Aktiengesellschaft Price Performance
The stock has a market cap of $29.40 billion, a price-to-earnings ratio of -33.41, a PEG ratio of 36.39 and a beta of 0.97. The firm has a fifty day moving average of €26.31 and a 200 day moving average of €23.49.
About Bayer Aktiengesellschaft
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Articles
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access